Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
If eating feels like a chore right now, please know youre not alone
Parameters reported in animal studies are specific to those study designs and are not validated for human use
The GLP-1 story is one were watching closely because it validates what our clinical team has long understood: the body and mind dont operate in separate silos
It now sits within a growing gray-market peptide ecosystem that includes compounds such as BPC-157 (marketed for healing and recovery), TB-500 (muscle repair), KPV (anti-inflammatory use), MOTS-c (metabolic performance), Epitalon (anti-aging), Semax (cognitive enhancement), DSIP (sleep and recovery), and Melanotan II itself, despite limited clinical evidence and lack of regulatory approval
92% Ninety-two percent of people who newly started glucagon-like peptide-1 (GLP-1) agonist drugs for weight loss were no longer taking the drug after three years
What the Phase 3 Trial Found In the Phase 3 ATTAIN-1 trial, more than 3,000 adults with obesity or overweight received daily doses of orforglipron alongside lifestyle changes
US$ 26.04
US$ 22.66
US$ 27.82
US$ 22.55
